UM

Browse/Search Results:  1-1 of 1 Help

Selected(0)Clear Items/Page:    Sort:
Rosiglitazone protects diabetic rats against kidney disease through the suppression of renal moncyte chemoattractant protein-1 expression Journal article
Zheng M., Ye S., Zhai Z., Chen Y., Li X., Yang G., Fan A., Wang Y.. Rosiglitazone protects diabetic rats against kidney disease through the suppression of renal moncyte chemoattractant protein-1 expression[J]. Journal of Diabetes and its Complications, 2009, 23(2), 124-129.
Authors:  Zheng M.;  Ye S.;  Zhai Z.;  Chen Y.;  Li X.; et al.
Favorite | TC[WOS]:26 TC[Scopus]:28 | Submit date:2019/01/16
Diabetes Mellitus  Diabetic Mephropathy  Monocyte Chemoattractant Protein-1  Rosiglitazone